Lutein, Zeaxathin, and Fish Oil Supplementation

Part of paid clinical trials in College Station, Texas.

Sponsor
Texas A&M University
Study ID
NCT06489873
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 45 Years
Healthy Volunteers
Accepted

Interventions

  • Active Comparator (Lutein, zeaxanthin, and fish oil supplement (LZF) — DIETARY_SUPPLEMENT
    Each participant will be assigned to t a LZF supplement daily for six months
  • Placebo Comparator — DIETARY_SUPPLEMENT
    Each participant will be assigned to take a placebo supplement daily for six months

Study Details

The goal of this clinical trial is to learn the impact of lutein, zeaxanthin, and fish oil (LZF) supplementation in healthy adults. The main question it aims to answer is: Will supplementation with LZF improve macular pigment optical density (MPOD), cognitive performance and bone mass compared to controls after six months? Subjects with an MPOD \<.43 will significantly improve MPOD after 6-months of LZF supplementation. Consuming a LZFO supplement for 6-months will improve visual cognitive performance. Consuming a LZFO supplement for 6-months will improve bone density. Participants will be asked to take either a LZF supplement or placebo daily for 6 months.

Key Dates

Start date
Feb 7, 2024
Status verified
Sep 2025
Primary completion
May 1, 2026
Completion
May 1, 2026

Study Design

Enrollment
80 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Active Comparator: LZF Supplement
    Participants will take one LZF supplement daily for six months.
  • Placebo Comparator: Placebo
    Participants will take on placebo supplement daily for six months.

Primary Outcome Measure

Macular Pigment Optical Density (MPOD) [ Time Frame: MPOD will be measured at baseline, 3 months after the start of the study, and at the final 6 month visit, which will be the completion of the study. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Gilchrist BuildingCollege StationTexas77843
Steven E. Riechman, PhD
[email protected]
979-862-3213
Karen M. Beathard, PhD
[email protected]
979-220-2281

Find similar trials in College Station, TX

By condition
Age-related macular degeneration
By specialty
OphthalmologyRetina
By research site
Gilchrist Building· College Station, TX

Related Studies